Point72 Middle East FZE’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,469
Closed -$19.1K 529
2023
Q4
$19.1K Sell
1,469
-4,874
-77% -$63.2K ﹤0.01% 815
2023
Q3
$127K Buy
6,343
+614
+11% +$12.3K ﹤0.01% 617
2023
Q2
$154K Buy
+5,729
New +$154K ﹤0.01% 644
2023
Q1
Sell
-3,150
Closed -$161K 1371
2022
Q4
$161K Buy
+3,150
New +$161K 0.01% 630